Angewandte
Communications
Chemie
for the formation of (S)-1 controlled by catalyst H. The
geometry of H was generated from our X-ray crystallographic
data of catalyst C (Figure 1b)[16] showing that the cinchona
alkaloid exists in an open conformation.[17] The absolute
configuration of product 1h determined by X-ray diffraction
(Figure 1a) was used as a model for the reacting enantiotopic
fluoromethyl group of substrates 2. The free OH group at the
prostereogenic carbon center and the OMe group of the
quinoline moiety of H should play important roles based on
the results of the catalyst screening (see entries 1, 3, and 6 in
Table 1). Hence, the transition-state structure TS-I is pro-
posed. The OH captures the anions of carbamates 2, by
intermolecular hydrogen bonding to the oxygen.[18] Addition-
ally, the carbamate anion is stabilized by ion pairing with
ammonium cation. These attractions facilitate the location of
the substrate 2 in the space between the left part of the
quinuclidine ring and the bulky bis(trifluormethyl)benzyl
group on the right. Steric repulsion induced by an ortho-
substituted aryl group efficiently moves away the benzyl
moiety of catalyst H and locks TS-I. The opposite side of the
quinoline moiety of H is blocked by its methoxy group, which
further confines the substrate molecules within the restricted
space of catalyst H (Figure 1c).
Keywords: asymmetric synthesis · C–F bond activation ·
desymmetrization · fluorine · organocatalysis
[1] a) R. E. Banks, D. W. A. Sharp, J. C. Tatlow, Fluorine—The First
Hundred Years (1886 – 1986), Elsevier, Amsterdam, 1986;
b) Organofluorine Chemistry. Principles and Commercial Appli-
cations (Eds. R. E. Banks, B. E. Smart, J. C. Tatlow), Plenum
´
Press, New York, 1994; c) M. Hudlicky, A. E. Pavlath, Chemistry
of Organic Fluorine Compounds II, A Critical Review, ACS
Monograph 187, American Chemical Society, Washington, 1995;
d) “Organofluorine Chemistry. Fluorinated Alkenes and Reactive
Intermediates” R. D. Chambers, in Topics in Current Chemistry,
Vol. 192, Springer, Berlin, 1997; e) R. E. Banks, Fluorine
Chemistry at the Millennium: Fascinated by Fluorine, Elsevier,
Amsterdam, 2000; f) T. Hiyama, Organofluorine Compounds.
Chemistry and Applications, Springer, Berlin, 2000; g) R. D.
Chambers, Fluorine in Organic Chemistry, Blackwell, Oxford,
2004; h) K. Uneyama, Organofluorine Chemistry, Blackwell,
Oxford, 2006; i) P. Kirsch, Modern Fluoroorganic Chemistry,
2nd ed., Wiley-VCH, Weinheim, 2013.
[2] a) Fluorine-Containing Synthons, ACS Symposium Series 911
(Ed. V. A. Soloshonok), American Chemical Society, Washing-
ton, 2005; b) Science of Synthesis Fluorine, Vol. 34 (Ed. J. M.
Percy), Thieme, Stuttgart, 2006; c) Handbook of Reagents for
Organic Synthesis: Fluorine-Containing Reagents (Ed. L. A.
Paquette), Wiley, New York, 2007; d) Fluorinated Heterocyclic
Compounds: Synthesis Chemistry, and Applications, (Ed. V. A.
Petrov), Wiley, Chichester, 2009; e) Fluorinated Heterocycles,
ACS Symposium Series, Vol. 1003, (Eds. A. A. Gakh, K. L.
Kirk), Amarican Chemical Society, Washington, 2009; f) Fluo-
rine in Heterocyclic Chemistry, Vols. 1 and 2, (Ed. V. G.
Nenajdenko), Springer, Wien, 2014.
[3] a) Fluorine-carbon and Fluoride-carbon Materials: Chemistry,
Physics and Application (Ed. T. Nakajima), Marcel Dekker,
Banner, S. Bendels, M. Kansy, B. Kuhn, K. Mꢀller, U. Obst-
OꢁHagan, Chem. Soc. Rev. 2008, 37, 308 – 319; f) R. Berger, G.
[4] a) J. T. Welch, S. Eswarakrishnan, Fluorine in Bioorganic
Chemistry, Wiley, Chichester, 1991; b) Biomedical Frontiers of
Fluorine Chemistry, ACS Symposium Series, Vol. 639 (Eds. I.
Ojima, J. R. McCarthy, J. T. Welch), American Chemical Society,
Washington, 1996; c) Enantiocontrolled Synthesis of Fluoroor-
ganic Compounds. Stereochemical Challenges and Biomedical
Targets (Ed. V. A. Soloshonok), Wiley, Chichester, 1999; d) Flu-
orine and Health: Molecular Imaging, Biomedical Materials and
Pharmaceuticals (Eds. A. Tressaud, G. Haufe), Elsevier, Amster-
dam, 2008; e) J. P. Bꢂguꢂ, D. Bonnet-Delpon, Bioorganic and
Medicinal Chemistry of Fluorine, Wiley, Hoboken, 2008; f) W. K.
320 – 330; h) Fluorine in Medicinal Chemistry and Chemical
Biology (Ed. I. Ojima), Wiley-Blackwell, Oxford, 2009; i) Fluo-
rine in Pharmaceutical and Medicinal Chemistry, From Biophys-
ical Aspects to Clinical Applications (Eds. V. Gouverneur, K.
Mꢀller), Imperial College Press, London, 2012; j) I. Ojima, J.
Rosellꢄ, J. L. AveÇa, C. del Pozo, A. E. Sorochinsky, S. Fustero,
l) E. P. Gillis, K. J. Eastman, M. D. Hill, D. J. Donnelly, N. A.
In conclusion, we have achieved the first asymmetric
desymmetrization of 1,3-difluorides using N,O-bis(trimethyl-
silyl)acetamide and catalyzed by a cinchona alkaloid derived
ammonium bifluoride salt providing chiral, non-racemic 3,5-
diaryl-5-fluoromethyloxazolidin-2-ones in high yields with
high enantioselectivities of up to 92% ee. Since the 3,5-diaryl-
5-trifluoromethyloxazolidin-2-ones are promising agrochem-
icals (insecticides, acaricides, ectoparasiticides),[19] mono-
fluorinated analogues are highly desirable. A notoriously
À
difficult non-activated aliphatic C F bond scission was
À
realized and a metal-free, silicon-mediated selective C F
bond activation was a key step. The combination of a cinchona
alkaloid based chiral ammonium bifluoride catalyst and
a silicon reagent enabled the efficient, asymmetric cleavage
À
of Csp3 F bonds under mild conditions with high enantiose-
lectivities. The remarkable steric effect of an ortho-substi-
tuted aryl group at the prostereogenic carbon for asymmetric
induction is observed not only for MeO, but also other alkoxy
groups, halogens, and bigger aryl groups. This concept of
À
asymmetric C F bond activation might be applicable for
other types of asymmetric synthesis with cyclization. This idea
is now under consideration.
Acknowledgments
This research is partially supported by the Platform for Drug
Discovery, Informatics and Structural Life Science from The
Ministry of Education, Culture, Sports, Science and Technol-
ogy-Japan (MEXT), and Japan Agency for Medical Research
and Development (AMED), the Advanced Catalytic Trans-
formation (ACT-C) from the JST Agency, and the Kobayashi
International Foundation. We also acknowledge the help of
Chisato Terada at the beginning of this research.
4
ꢀ 2016 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Angew. Chem. Int. Ed. 2016, 55, 1 – 6
These are not the final page numbers!